活化蛋白-1和糖皮质激素受体在慢性阻塞性肺疾病中的作用
摘要
慢性阻塞性肺疾病(COPD)以气道慢性炎症为主要特征,糖皮质激素是强有力的抗炎药物,但对COPD的治疗效果不太理想。活化蛋白1和糖皮质激素受体的表达水平及活性状态是影响激素疗效的重要因素,本文针对活化蛋白1和糖皮质激素受体在COPD发病中的作用以及对激素治疗的关系作一综述。
出处
《国际呼吸杂志》
2006年第3期189-191,共3页
International Journal of Respiration
参考文献19
-
1Caramori G,Ito K,Adcock IM.Transcription factors in asthma and COPD.Drugs,2004,7(8):764-770.
-
2Cosio BG,Torrego A,Adcock IM.Molecular mechanisms of glucocorticoids.Arch Bronconeumol,2005,41 (1):34-41.
-
3Barnes PJ.Corticosteroid Resistance in Airway Disease.Proc ATS,2004,1 (3):264-268.
-
4Bobrovnikova-Marjon EV,Marjon PL,Barbash O,et al.Expression of angiogenic factors vascular endothelial growth factor and interleukin-8/CXCL8 is highly responsive to ambient glutamine availability:role of nuclear factor-kappaB and activating protein-1.Cancer Res,2004,64(14):4858-4869.
-
5Barczyk A,Sozanska E,Trzaska M,et al.Decreased levels of myeloperoxidase in induced sputum of patients with COPD after treatment with oral glucocorticoids.Chest,2004,126 (2):389-393.
-
6Rahman I,MacNee W.Role of transcription factors in inflammatory lung diseases.Thorax,1998,53(7):601-606.
-
7Brown DM,Donaldson K,Borm PJ,et al.Calcium and ROS-mediated activation of transcription factors and TNF-alpha cytokine gene expression in macrophages exposed to ultrafine particles.Am J Physiol Lung Cell Mol Physiol,2004,286 (2):L344-353.
-
8Woo CH,Lim JH,Kim JH.Lipopolysaccharide induces matrix metalloproteinase-9 expression via a mitochondrial reactive oxygen species-p38 kinase-activator protein-1 pathway in Raw 264.7cells.J Immunol,2004,173(11):6973-6980.
-
9Aljada A,Ghanim H,Mohanty P,et al.Hydrocortisone suppresses intranuclear activator protein-1 (AP-1) binding activity in mononuclear cells and plasma matrix metalloproteinase-2 and-9 (MMP-2 and MMP-9).J Clin Endocrinol Metab,2001,86(12):5988-5991.
-
10Korn SH,Thunnissen FB,Wesseling GJ,et al.Glucocorticoid receptor mRNA levels in bronchial epithelial cells of patients with COPD:influence of glucocorticoids.Respir Med,1998,92 (9):1102-1109.
-
1胡国梅,王国贤,李飞.芒果苷对糖尿病大鼠心肌损伤保护作用[J].中国公共卫生,2013,29(12):1796-1799. 被引量：7
-
2寿成珉,李红.活性氧簇与糖尿病肾病[J].国外医学（内分泌学分册）,2005,25(B04):27-29.
-
3徐永红,刘荣玉.活化蛋白-1及糖皮质激素受体在慢性阻塞性肺疾病中的表达及意义[J].中华老年医学杂志,2006,25(8):600-601.
-
4许建英,安晓洁,庞敏,杜永成.不同药物对香烟诱导的大鼠肺泡巨噬细胞氧化应激相关因子表达的影响[J].中国现代医学杂志,2007,17(16):1977-1982.
-
5李冬冬,莫小华.还原型谷胱甘肽对急性胰腺炎治疗作用机制的研究现状[J].昆明医科大学学报,2009,32(S2):290-292.
-
6任法新,方毅民,杨军,刘少荣,张传焕.急性冠状动脉综合征患者外周血单个核细胞核因子-κB和糖皮质激素受体及活化蛋白-1的表达[J].中华临床医师杂志（电子版）,2010,4(9):108-111. 被引量：3
-
7罗爽.糖皮质激素治疗特发性血小板减少性紫癜的疗效[J].求医问药（下半月）,2013(9):279-280.
-
8刘东辉.糖皮质激素在慢性阻塞性肺疾病急性加重患者的临床应用观察[J].健康导报（医学版）,2015,20(11):41-41.
-
9吴珺,鹿英英,姚国滟,张一杰.普米克令舒联合可必特雾化吸入治疗慢性阻塞性肺疾病急性加重期的疗效分析[J].首都医药,2010,17(14):51-52.
-
10刘汉锋.特发性血小板减少性紫癜的临床及相关因素分析[J].临床医学,2000,20(3):4-6. 被引量：1
